Navigation Links
Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
Date:3/3/2011

BLUE BELL, Pa., March 3, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Dr. J. Joseph Kim, President and CEO, will present a company overview at the ROTH 23rd Annual Growth Stock Conference being held March 13-16 at the Ritz-Carlton, Laguna Niguel, CA.

A live and archived webcast will be accessible on Inovio's website at www.inovio.com.Inovio Presentation The Ritz-CarltonMonday, March 142:30 pm PTConference details: http://www.roth.com/main/Page.aspx?PageID=7236

About Inovio Pharmaceuticals, Inc. Inovio is developing a new generation of vaccines, called DNA vaccines, to treat and prevent cancers and infectious diseases. These SynCon™ vaccines are designed to provide broad cross-strain protection against known as well as newly emergent strains of pathogens such as influenza. These vaccines, in combination with Inovio's proprietary electroporation delivery devices, have been shown to be safe and generate significant immune responses. Inovio's clinical programs include HPV/cervical dysplasia and cancer (therapeutic), avian flu (preventive), and HIV vaccines (both preventive and therapeutic). Inovio is developing universal influenza and other vaccines in collaboration with scientists from the University of Pennsylvania. Other partners and collaborators include Merck, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our p
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
2. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
3. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
4. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
5. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
6. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
7. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the Cowen and Company 31st Annual Health Care Conference in Boston on March 9, 2011
8. Onyx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
9. Savient Pharmaceuticals to Present at the 31st Annual Cowen & Co. Health Care Conference
10. Accumetrics Signs Development & Supply Agreement With Portola Pharmaceuticals, Inc.
11. Handa Pharmaceuticals Announces Submission of Its First-to-File ANDA for Takedas DEXILANT®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... Conn. , June 3, 2015  SurgiQuest®, ... innovative access technologies for minimally invasive surgery (MIS) ... AirSeal® System in over 250,000 procedures.  Adoption has ... procedures over last year, driven by the company,s ... as well as geographic expansion to over 45 ...
(Date:6/3/2015)... -- Research and Markets  ( http://www.researchandmarkets.com/research/rf4hfn/global ) has ... Diseases Market 2015-2019" report to their offering. ... grow at a CAGR of 4.77% over the ... present scenario and the growth prospects of the ... To calculate the market size, the report considers ...
(Date:6/3/2015)... CAMBRIDGE, Mass. , June 3, 2015  EIP ... dosing in phase 2 clinical development of VX-745 in ... brain penetrant, highly selective and potent inhibitor of the ... protein kinase (p38 MAPK alpha). "Recent human ... of disease in patients with symptomatic Alzheimer,s, while the ...
Breaking Medicine Technology:Rapid Procedure Growth With SurgiQuest's AirSeal System 2Global Neurodegenerative Diseases Market 2015-2019 - Reformulation of Marketed Drugs 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 2EIP Pharma announces first patient dosing in phase 2 clinical studies of a novel brain-targeted anti-inflammatory drug candidate, VX-745, for the treatment of Alzheimer's disease (AD) 3
... , April 26 Sirion Therapeutics, Inc., a ... ophthalmic gel) 0.15% is now commercially available.  Zirgan™, which was ... September 2009 , is a topical ophthalmic antiviral indicated for ... , , ...
... TARRYTOWN, N.Y. , April 26 Bayer Diabetes ... blood glucose monitoring system in the United States . ... the only blood glucose meter that connects directly to Nintendo ... kids manage a lifelong disease by rewarding them for building ...
Cached Medicine Technology:Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 2Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 3Bayer Diabetes Care Introduces DIDGET In the US 2Bayer Diabetes Care Introduces DIDGET In the US 3Bayer Diabetes Care Introduces DIDGET In the US 4Bayer Diabetes Care Introduces DIDGET In the US 5
(Date:6/3/2015)... June 03, 2015 Researchers at the ... for mesothelioma and say the tried-and-true marker mesothelin is ... an article on the research. Click here to ... National Center for Asbestos Related Diseases say, even though ... it is still preferable to fibulin-3 for identifying mesothelioma. ...
(Date:6/3/2015)... (PRWEB) June 03, 2015 According to ... police officers intercepted fake oxycodone pills which actually ... were doctored to look legitimate, and even sported the ... are warning those consuming 30 mg oxycodone to be ... pills online or buy them illegally on the street. ...
(Date:6/3/2015)... June 03, 2015 Fourroux Prosthetics, located ... GA will celebrate its grand opening with a ribbon ... first prosthetic center of its kind in the area, ... unmatched care and outcomes through use of patented advanced ... & CEO of Fourroux Prosthetics, states, “Our goal has ...
(Date:6/3/2015)... June 03, 2015 DailyEndorphin is pleased ... programming module. With this highly configurable new offering, ... report on many components of its wellness programming for ... additional charge. , With this new module, annual clients ... challenges, (2) Create participant surveys, (3) Continually report on ...
(Date:6/3/2015)... June 03, 2015 On May 29, ... Authorization (MA), effective immediately, which now permits the use ... contain oats as ingredients. The MA is a prelude ... All stakeholders should be aware that, unlike the unlimited ... USA, there are restrictions for gluten-free oat products sold ...
Breaking Medicine News(10 mins):Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 2Health News:Fake Oxycodone Pills of Fentanyl Discovered in Tennessee by Police 3Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:DailyEndorphin Launches Wellness "Events" Portal 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 2Health News:Health Canada Allows For Conditional Use Of Gluten-Free Oats 3
... 21 The Hispanic got milk? Milk Mustache Mobile,Drink Well. ... tour, including,the top 10 Hispanic cities, to reintroduce Hispanics to ... cruised through Denver,hosting free events to encourage local residents to ... drink -- milk. , At the ...
... Challenges for the Summer of 2009NEW YORK, May 21 ... in Manhattan, Long Island, Hudson Valley, Brooklyn / Staten Island, ... to maintain an adequate and safe blood supply for hospital ... Flu) , Some high school blood ...
... Economic Times Bring Experienced Nurses Back To Job MarketBERKELEY, Calif., ... nurses at hospitals -- a result of the economic recession ... Jones, RN, MS, executive director of the California Institute for ... in hospitals, so a slow down in admissions is just ...
... linked to higher stress levels in adolescence , , THURSDAY, May ... time in child-care facilities or who had insensitive mothers may ... long-term study suggests. , The conclusion is based on a ... , that by age 15 these children are more ...
... May 21 St. David,s HealthCare was named the number ... third consecutive year at the Austin Business Journal ,s ... 2009."Being named a ,Best Place to Work, is a tribute ... St. David,s HealthCare; our business is a team effort, and ...
... fewer signs of condition , , THURSDAY, May 21 (HealthDay News) ... has been identified by U.S. researchers, who said their finding ... , The researchers found that mice without the ion channel ... to normal mice, those lacking the gene for TRPA1 had ...
Cached Medicine News:Health News:The Hispanic got milk? Campaign Visited Denver May 17th - May 20th 2Health News:It's Summer; Patients Need Us to Donate Blood! 2Health News:Hard Times for Nursing Hires Doesn't Signal End to Shortage According to California Institute for Nursing & Health Care 2Health News:Teen Stress May Have Roots in First Three Years of Life 2Health News:St. David's HealthCare Named #1 Best Place to Work Among Large Central Texas Employers for Third Consecutive Year 2
... With the GE Innova 2100IQ: See the ... legs. Place interventional devices. Its all enabled ... panel that helps deliver excellent image quality ... Innova family systems installed worldwide, more physicians ...
... provides clinically valuable, device-derived information applicable ... to help specialty physicians discern if ... stable or deteriorating. For example, heart ... Medtronic InSync Sentry™ CRT-D system can ...
... (ALS) is a GH dependent protein which is ... acid peptide with a predicted molecular weight of ... confined to a ~150 KDa GH-dependent ternary protein ... or IGF-II, and this unique acid-labile subunit (ALS) ...
... was first identified in 1980 (1) and has ... of appetite (2). PYY is produced by the ... intake, and is found to decrease appetite. The ... the circulation is PYY3-36, the N-terminal truncated form ...
Medicine Products: